These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 25521075
1. Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21. Mei L, Chen Y, Wang Z, Wang J, Wan J, Yu C, Liu X, Li W. Br J Pharmacol; 2015 May; 172(9):2232-45. PubMed ID: 25521075 [Abstract] [Full Text] [Related]
2. Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy. Yu M, Liu T, Chen Y, Li Y, Li W. J Exp Clin Cancer Res; 2018 Jun 04; 37(1):114. PubMed ID: 29866132 [Abstract] [Full Text] [Related]
3. Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma. Gong K, Chen C, Zhan Y, Chen Y, Huang Z, Li W. J Biol Chem; 2012 Oct 12; 287(42):35576-35588. PubMed ID: 22927446 [Abstract] [Full Text] [Related]
4. Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy. Huang AC, Lien JC, Lin MW, Yang JS, Wu PP, Chang SJ, Lai TY. Int J Oncol; 2013 Aug 12; 43(2):485-94. PubMed ID: 23695424 [Abstract] [Full Text] [Related]
5. Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. Liu C, Gong K, Mao X, Li W. Int J Cancer; 2011 Sep 15; 129(6):1519-31. PubMed ID: 21128229 [Abstract] [Full Text] [Related]
6. Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling. Wan J, Liu T, Mei L, Li J, Gong K, Yu C, Li W. Br J Cancer; 2013 Jul 23; 109(2):342-50. PubMed ID: 23807172 [Abstract] [Full Text] [Related]
7. Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo. Xiao W, Jiang Y, Men Q, Yuan L, Huang Z, Liu T, Li W, Liu X. Int J Oncol; 2015 Jan 23; 46(1):360-8. PubMed ID: 25355542 [Abstract] [Full Text] [Related]
8. Tetrandrine enhances antitumor effects of the histone deacetylase inhibitor MS-275 in human cancer in a Bax- and p53-dependent manner. Li H, Xu X, Zhang Y, Tang X, Li W. Eur J Pharmacol; 2020 Dec 05; 888():173575. PubMed ID: 32950498 [Abstract] [Full Text] [Related]
9. The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex. Chen L, Li G, Peng F, Jie X, Dongye G, Cai K, Feng R, Li B, Zeng Q, Lun K, Chen J, Xu B. Oncotarget; 2016 Dec 06; 7(49):80716-80734. PubMed ID: 27811372 [Abstract] [Full Text] [Related]
10. Autophagy inhibition enhances photocytotoxicity of Photosan-II in human colorectal cancer cells. Xiong L, Liu Z, Ouyang G, Lin L, Huang H, Kang H, Chen W, Miao X, Wen Y. Oncotarget; 2017 Jan 24; 8(4):6419-6432. PubMed ID: 28031534 [Abstract] [Full Text] [Related]
11. Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Wu JM, Chen Y, Chen JC, Lin TY, Tseng SH. Cancer Lett; 2010 Jan 28; 287(2):187-95. PubMed ID: 19586712 [Abstract] [Full Text] [Related]
12. Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells. Liu T, Men Q, Wu G, Yu C, Huang Z, Liu X, Li W. Oncotarget; 2015 Apr 10; 6(10):7992-8006. PubMed ID: 25797266 [Abstract] [Full Text] [Related]
13. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells. Tsai JP, Lee CH, Ying TH, Lin CL, Lin CL, Hsueh JT, Hsieh YH. Oncotarget; 2015 Oct 06; 6(30):28851-66. PubMed ID: 26311737 [Abstract] [Full Text] [Related]
14. Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells. Liu JT, Li WC, Gao S, Wang F, Li XQ, Yu HQ, Fan LL, Wei W, Wang H, Sun GP. Clin Lung Cancer; 2015 Sep 06; 16(5):e55-66. PubMed ID: 25979647 [Abstract] [Full Text] [Related]
15. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Meng LH, Zhang H, Hayward L, Takemura H, Shao RG, Pommier Y. Cancer Res; 2004 Dec 15; 64(24):9086-92. PubMed ID: 15604277 [Abstract] [Full Text] [Related]
16. Tetrandrine isolated from Cyclea peltata induces cytotoxicity and apoptosis through ROS and caspase pathways in breast and pancreatic cancer cells. N B, Chandrashekar KR, Prabhu A, Rekha PD. In Vitro Cell Dev Biol Anim; 2019 May 15; 55(5):331-340. PubMed ID: 30945115 [Abstract] [Full Text] [Related]
17. Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy. Lien JC, Lin MW, Chang SJ, Lai KC, Huang AC, Yu FS, Chung JG. Environ Toxicol; 2017 Jan 15; 32(1):329-343. PubMed ID: 26822499 [Abstract] [Full Text] [Related]
18. ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21((CIP1/WAF1)) in human cancer cells. Li J, Chen Y, Wan J, Liu X, Yu C, Li W. Br J Pharmacol; 2014 Jul 15; 171(13):3182-95. PubMed ID: 24571452 [Abstract] [Full Text] [Related]
19. Anticancer activity of tetrandrine by inducing pro-death apoptosis and autophagy in human gastric cancer cells. Bai XY, Liu YG, Song W, Li YY, Hou DS, Luo HM, Liu P. J Pharm Pharmacol; 2018 Aug 15; 70(8):1048-1058. PubMed ID: 29770446 [Abstract] [Full Text] [Related]
20. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells. Hwang KE, Kim YS, Jung JW, Kwon SJ, Park DS, Cha BK, Oh SH, Yoon KH, Jeong ET, Kim HR. Oncotarget; 2015 Oct 06; 6(30):29482-96. PubMed ID: 26334320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]